Dr. Agarwal's Eye Hospital Limited (DRAGARWQ.BO)
BSE · INR · Healthcare · Medical Care Facilities
₹5,249.35 (+1.42%) as of
Key statistics
- Market cap
- 25.37B
- P/E (TTM)
- 33.06
- Forward P/E
- 540.06
- EPS (TTM)
- 158.78
- Dividend yield
- 0.14%
- 52-week range
- 4,412.05 – 6,392.00
- Beta
- -0.54
- Revenue (TTM)
- 4.97B
- Profit margin
- 15.34%
- Volume
- 122.00
About Dr. Agarwal's Eye Hospital Limited
Dr. Agarwal's Eye Hospital Limited engages in the provision of eye care and related services in India, Ghana, Uganda, Kenya, Madagascar, Tanzania, Rwanda, Zambia, Mozambique, and Mauritius. The company, through its hospitals, offers services in the areas of cataract, glaucoma, laser correction, cornea and refractive, retina, squint, corneal ulcer, fungal keratitis, diabetic retinopathy, retinal detachment, nystagmus, ptosis, conjunctivitis, retinopathy prematurity, macular hole and edema, cornea transplantation, behcets, computer vision syndrome, hypertensive retinopathy, black fungus, traumatic cataract, keratoconus, uveitis, pterygium, blepharitis, posterior subcapsular cataract, pinhole pupilloplasty, rosette cataract, and congenital glaucoma. It also operates opticals and pharmacies and is engaged in the sale of optical frames, contact lenses, accessories, and pharmaceutical products. Dr. Agarwal's Eye Hospital Limited was founded in 1957 and is based in Chennai, India. Dr. Agarwal's Eye Hospital Limited operates as a subsidiary of Dr. Agarwal's Health Care Limited.
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Headquarters
- Chennai, India
- Employees
- 1,356
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.